???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
David Otaegui BIchot

Nomes de citação

  • Otaegui, David

Identificadores de autor

Ciência ID
2612-00B1-7315
ORCID iD
0000-0002-6625-5976
Google Scholar ID
hHJ9ljQAAAAJ&hl
Researcher Id
H-4390-2013
Scopus Author Id
8367001900

Telefones

Telefone
  • (+34) 943006293 (Profissional)

Moradas

  • Instituto Biodonostia. Paseo Dr Begiristain s/n, 20016, San Sebastian, San Sebastián, Espanha (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Básica - Neurociências

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Espanhol; Castelhano (Idioma materno)
Inglês Utilizador independente (B2) Utilizador independente (B2) Utilizador independente (B2) Utilizador independente (B2) Utilizador independente (B2)
Formação
Grau Classificação
2002/01/01 - 2007/06/15
Concluído
 Doctor en genética (Doctor)
Universidad del País Vasco, Espanha
"Susceptibilidad genética en la Esclerosis Múltiple" (TESE/DISSERTAÇÃO)
 Cum Laude
1994/09/01 - 1999/09/01
Concluído
 Bioquímica (Licence)
Universidad del País Vasco, Espanha
 NOtable
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2007/07/01 - Atual Investigador (Investigação) Osakidetza-Servicio Vasco de Salud, Espanha
Biodonostia Instituto de Investigación Sanitaria, Espanha
2002/09/01 - 2007/06/01 Investigador (Investigação) Gobierno Vasco, Espanha
Hospital Universitario de Donostia, Espanha
2005/03/01 - 2005/06/01 Investigador visitante (Investigação) Gobierno Vasco, Espanha
University of California San Francisco, Estados Unidos
2001/09/10 - 2002/08/01 Investigador visitante (Investigação) Gobierno Vasco, Espanha
Columbia University Department of Neurology, Estados Unidos
1999/11/01 - 2001/09/01 Investigador (Investigação) Gobierno Vasco, Espanha
Hospital Universitario de Donostia, Espanha
Projetos

Bolsa

Designação Financiadores
2021/01 - 2024/01 Implicación de los RNA circulares en la esclerosis múltiple; algo más que un biomarcador
PI20/1253
 Instituto de Salud Carlos III
2019 - 2022 Inmunosenescencia en la esclerosis múltiple
2019111039
 Gobierno Vasco Departamento de Salud
2018/01 - 2021/01 RNA circulares y su implicación en la esclerosis múltiple
PI17/00189
 Instituto de Salud Carlos III
2016/01 - 2020/01 Red española de esclerosis múltiple
RD16/0015/0007
 Instituto de Salud Carlos III
2019 - 2020 Implicación de la microbiota y los ácidos grasos de cadena corta en el inicio y evolución de la esclerosis múltiple
REEM1
 Instituto de Salud Carlos III
2018 - 2019 5. Vesículas extracelulares como vehículo de sncRNA al sistema nervioso central
2018222025
 Gobierno Vasco Departamento de Salud
2016/01 - 2017/01 • Investigación colaborativa en nuevas técnicas de imagen y biomateriales para el diagnóstico y tratamiento de enfermedades del sistema Nervioso
ELKARTEK 2016-2017
 Gobierno Vasco
2015/01 - 2017/01 Vehiculización de moléculas terapéuticas al SNC. Administración intranasal de nanopartículas para la vehiculización de moléculas remielinizantes en un modelo de encefalitis autoinmune experimental
DTS15/00069
 Instituto de Salud Carlos III
2014/01 - 2017/01 Papel de las vesículas extracelulares como promotoras de la remielinización en la esclerosis múltiple. 90750 €. Fondo de investigación Sanitaria
PI14/00939
 Instituto de Salud Carlos III
2015/01 - 2016/09 Estudio de moléculas remielinizantes en el SNC. Administración intranasal de nanopartículas para la vehiculización de moléculas remielinizantes en un modelo de encefalitis autoinmune experimental
DFG15/006
 Diputación Foral de Gipuzkoa
2012/01 - 2014 Red española de esclerosis múltiple
2012-2016
 Instituto de Salud Carlos III
2012 - 2014 Rol de las micropartículas como biomarcador en EM. Gobierno Vasco.
GV-2011111028
 Gobierno Vasco
2013 - 2013 - SAIO 13. Biomarcadores en la esclerosis múltiple
SAIO 13
 Gobierno Vasco
2012 - 2012 LMP en la esclerosis múltiple. Saiotek
SAIO 12
 Gobierno Vasco
2011 - 2012 Análisis genético y clínico en familias vascas con esclerosis múltiple
DFG11/005
 Diputación de Gipuzkoa
Produções

Publicações

Artigo em revista
  1. Leire Iparraguirre; Ainhoa Alberro; Lucía Sepúlveda; Iñaki Osorio-Querejeta; Laura Moles; Tamara Castillo-Triviño; Thomas B Hansen; Maider Muñoz-Culla; David Otaegui. "RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers". Human Molecular Genetics (2020): https://doi.org/10.1093/hmg/ddaa219.
    10.1093/hmg/ddaa219
  2. Leire Iparraguirre; Danel Olaverri; Telmo Blasco; Lucía Sepúlveda; Tamara Castillo-Triviño; Mercedes Espiño; Lucienne Costa-Frossard; et al. "Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease". Biomedicines 8 12 (2020): 540-540. https://doi.org/10.3390/biomedicines8120540.
    10.3390/biomedicines8120540
  3. Olatz Arrizabalaga; David Otaegui; Itziar Vergara; Julio Arrizabalaga; Eva Méndez. "Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed [version 2; peer review: 2 approved, 1 approved with reservations]". (2020): https://f1000research.com/articles/9-649/v2.
    10.12688/f1000research.24136.2
  4. Olatz Arrizabalaga; David Otaegui; Itziar Vergara; Julio Arrizabalaga; Eva Méndez. "Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMed". F1000Research (2020): https://doi.org/10.12688/f1000research.24136.1.
    10.12688/f1000research.24136.1
  5. Laura Moles; David Otaegui. "The Impact of Diet on Microbiota Evolution and Human Health. Is Diet an Adequate Tool for Microbiota Modulation?". Nutrients 12 6 (2020): 1654-1654. https://doi.org/10.3390/nu12061654.
    10.3390/nu12061654
  6. Elia Gil-Varea; Maria Fedetz; Herena Eixarch; Nino Spataro; Luisa María Villar; Elena Urcelay; Albert Saiz; et al. "A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells". Journal of Clinical Medicine (2020): https://www.mdpi.com/2077-0383/9/3/625.
    10.3390/jcm9030625
  7. Paloma Gómez Fernández; Aitzkoa Lopez de Lapuente Portilla; Ianire Astobiza; Jorge Mena; Andoni Urtasun; Vivian Altmann; Fuencisla Matesanz; et al. "The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis". Cells (2020): https://www.mdpi.com/2073-4409/9/1/175.
    10.3390/cells9010175
  8. BIchot, David. "T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians". Aging (2019): http://dx.doi.org/10.18632/aging.102517.
    10.18632/aging.102517
  9. BIchot, David. "To Be or Not to Be: Circular RNAs or mRNAs From Circular DNAs?". Frontiers in Genetics (2019): http://dx.doi.org/10.3389/fgene.2019.00940.
    10.3389/fgene.2019.00940
  10. Itziar Lopetegi; Amaia Muñoz-Lopetegi; Maialen Arruti; Alvaro Prada; Sabin Urcelay; Javier Olascoaga; David Otaegui; Tamara Castillo-Triviño. "ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor". Multiple Sclerosis Journal - Experimental, Translational and Clinical 5 4 (2019): 205521731988895-205521731988895. https://doi.org/10.1177/2055217319888957.
    10.1177/2055217319888957
  11. BIchot, David. "Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges". Cancers (2019): http://dx.doi.org/10.3390/cancers11070950.
    10.3390/cancers11070950
  12. Sole C; Arnaiz E; Manterola L; Otaegui D; Lawrie CH. "The circulating transcriptome as a source of cancer liquid biopsy biomarkers.". Seminars in cancer biology (2019): http://europepmc.org/abstract/med/30684535.
    10.1016/j.semcancer.2019.01.003
  13. Arnaiz E; Sole C; Manterola L; Iparraguirre L; Otaegui D; Lawrie CH. "CircRNAs and cancer: Biomarkers and master regulators.". Seminars in cancer biology (2018): http://europepmc.org/abstract/med/30550956.
    10.1016/j.semcancer.2018.12.002
  14. Fernández-Eulate G; Alberro A; Muñoz-Culla M; Zulaica M; Zufiría M; Barandiarán M; Etxeberria I; et al. "Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidß Are Strongly Associated With Healthy Aging in the Oldest Old.". Frontiers in aging neuroscience (2018): http://europepmc.org/abstract/med/30546303.
    10.3389/fnagi.2018.00380
  15. Osorio-Querejeta I; Alberro A; Muñoz-Culla M; Mäger I; Otaegui D. "Therapeutic Potential of Extracellular Vesicles for Demyelinating Diseases; Challenges and Opportunities.". Frontiers in molecular neuroscience (2018): http://europepmc.org/abstract/med/30532691.
    10.3389/fnmol.2018.00434
  16. Sáenz-Cuesta M; Alberro A; Muñoz-Culla M; Osorio-Querejeta I; Fernandez-Mercado M; Lopetegui I; Tainta M; et al. "The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients.". International journal of molecular sciences (2018): http://europepmc.org/abstract/med/30126230.
    10.3390/ijms19082448
  17. Valderrama-Carvajal A; Irizar H; Gago B; Jiménez-Urbieta H; Fuxe K; Rodríguez-Oroz MC; Otaegui D; Rivera A. "Transcriptomic integration of D4R and MOR signaling in the rat caudate putamen.". Scientific reports (2018): http://europepmc.org/abstract/med/29743514.
    10.1038/s41598-018-25604-4
  18. Anasagasti A; Ezquerra-Inchausti M; Barandika O; Muñoz-Culla M; Caffarel MM; Otaegui D; López de Munain A; Ruiz-Ederra J. "Expression Profiling Analysis Reveals Key MicroRNA-mRNA Interactions in Early Retinal Degeneration in Retinitis Pigmentosa.". Investigative ophthalmology & visual science (2018): http://europepmc.org/abstract/med/29847644.
    10.1167/iovs.18-24091
  19. Iparraguirre L; Muñoz-Culla M; Prada-Luengo I; Castillo-Triviño T; Olascoaga J; Otaegui D. "Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis.". Human molecular genetics (2017): http://europepmc.org/abstract/med/28651352.
    10.1093/hmg/ddx243
  20. Osorio-Querejeta I; Sáenz-Cuesta M; Muñoz-Culla M; Otaegui D. "Models for Studying Myelination, Demyelination and Remyelination.". (2017): http://europepmc.org/abstract/med/28536996.
    10.1007/s12017-017-8442-1
  21. Muñoz-Culla M; Irizar H; Gorostidi A; Alberro A; Osorio-Querejeta I; Ruiz-Martínez J; Olascoaga J; López de Munain A; Otaegui D. "Progressive changes in non-coding RNA profile in leucocytes with age.". (2017): http://europepmc.org/abstract/med/28448962.
    10.18632/aging.101220
  22. Muñoz-Culla M; Sáenz-Cuesta M; Guereca-Barandiaran MJ; Ribeiro ML; Otaegui D. "Yerba mate (Ilex paraguariensis) inhibits lymphocyte activation in vitro.". (2016): http://europepmc.org/abstract/med/27714004.
    10.1039/c6fo01061j
  23. Fernández-Torrón R; García-Puga M; Emparanza JI; Maneiro M; Cobo AM; Poza JJ; Espinal JB; et al. "Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.". (2016): http://europepmc.org/abstract/med/27558368.
    10.1212/wnl.0000000000003124
  24. Li L; Muñoz-Culla M; Carmona U; Lopez MP; Yang F; Trigueros C; Otaegui D; Zhang L; Knez M. "Ferritin-mediated siRNA delivery and gene silencing in human tumor and primary cells.". (2016): http://europepmc.org/abstract/med/27187278.
    10.1016/j.biomaterials.2016.05.006
  25. Alberro A; Sáenz-Cuesta M; Muñoz-Culla M; Mateo-Abad M; Gonzalez E; Carrasco-Garcia E; Araúzo-Bravo MJ; et al. "Inflammaging and Frailty Status Do Not Result in an Increased Extracellular Vesicle Concentration in Circulation.". (2016): http://europepmc.org/abstract/med/27447627.
    10.3390/ijms17071168
  26. Muñoz-Culla M; Irizar H; Sáenz-Cuesta M; Castillo-Triviño T; Osorio-Querejeta I; Sepúlveda L; López de Munain A; Olascoaga J; Otaegui D. "SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.". (2016): http://europepmc.org/abstract/med/26831009.
    10.1038/srep20126
  27. Irizar H; Goñi J; Alzualde A; Castillo-Triviño T; Olascoaga J; Lopez de Munain A; Otaegui D. "Age gene expression and coexpression progressive signatures in peripheral blood leukocytes.". (2015): http://europepmc.org/abstract/med/26362218.
    10.1016/j.exger.2015.09.003
  28. Matesanz F; Potenciano V; Fedetz M; Ramos-Mozo P; Abad-Grau Mdel M; Karaky M; Barrionuevo C; et al. "A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis.". (2015): http://europepmc.org/abstract/med/26152201.
    10.1093/hmg/ddv256
  29. Fernandez-Mercado M; Manterola L; Larrea E; Goicoechea I; Arestin M; Armesto M; Otaegui D; Lawrie CH. "The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.". (2015): http://europepmc.org/abstract/med/26119132.
    10.1111/jcmm.12625
  30. Otaegui D; Masdeu C; Aldaba E; Vara Y; Zubia A; San Sebastian E; Alcalá M; et al. "Development and validation of a LC-MS assay for the quantification of ikh12 a novel anti-tumor candidate in rat plasma and tissues and its application in a pharmacokinetic study.". (2015): http://europepmc.org/abstract/med/25616154.
    10.1002/bmc.3414
  31. Martí Massó JF; Zarranz JJ; Otaegui D; López de Munain A. "Neurogenetic disorders in the Basque population.". (2015): http://europepmc.org/abstract/med/25440984.
    10.1111/ahg.12088
  32. Sáenz-Cuesta M; Mittelbrunn M; Otaegui D. "Editorial: Novel Clinical Applications of Extracellular Vesicles.". (2015): http://europepmc.org/abstract/med/26257745.
    10.3389/fimmu.2015.00381
  33. Irizar H; Muñoz-Culla M; Sáenz-Cuesta M; Osorio-Querejeta I; Sepúlveda L; Castillo-Triviño T; Prada A; et al. "Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.". (2015): http://europepmc.org/abstract/med/25880556.
    10.1186/s12864-015-1396-5
  34. Sáenz-Cuesta M; Arbelaiz A; Oregi A; Irizar H; Osorio-Querejeta I; Muñoz-Culla M; Banales JM; et al. "Methods for extracellular vesicles isolation in a hospital setting.". (2015): http://europepmc.org/abstract/med/25762995.
    10.3389/fimmu.2015.00050
  35. Muñoz-Culla M; Irizar H; Castillo-Triviño T; Sáenz-Cuesta M; Sepúlveda L; Lopetegi I; López de Munain A; et al. "Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.". (2014): http://europepmc.org/abstract/med/24852919.
    10.1177/1352458514534513
  36. Etxaniz U; Pérez-San Vicente A; Gago-López N; García-Dominguez M; Iribar H; Aduriz A; Pérez-López V; et al. "Neural-competent cells of adult human dermis belong to the Schwann lineage.". (2014): http://europepmc.org/abstract/med/25418723.
    10.1016/j.stemcr.2014.09.009
  37. Sistiaga A; Castillo-Triviño T; Aliri J; Gaztañaga M; Acha J; Arruti M; Otaegui D; Olascoaga J. "[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].". (2014): http://europepmc.org/abstract/med/24723176.
  38. Irizar H; Muñoz-Culla M; Sepúlveda L; Sáenz-Cuesta M; Prada Á; Castillo-Triviño T; Zamora-López G; et al. "Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.". (2014): http://europepmc.org/abstract/med/24587374.
    10.1371/journal.pone.0090482
  39. Sáenz-Cuesta M; Osorio-Querejeta I; Otaegui D. "Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?". (2014): http://europepmc.org/abstract/med/24734004.
    10.3389/fncel.2014.00100
  40. Sáenz-Cuesta M; Irizar H; Castillo-Triviño T; Muñoz-Culla M; Osorio-Querejeta I; Prada A; Sepúlveda L; et al. "Circulating microparticles reflect treatment effects and clinical status in multiple sclerosis.". (2014): http://europepmc.org/abstract/med/25123034.
    10.2217/bmm.14.9
  41. Paradas C; Camaño P; Otaegui D; Oz O; Emmanuele V; DiMauro S; Hirano M. "Longitudinal clinical follow-up of a large family with the R357P Twinkle mutation.". (2013): http://europepmc.org/abstract/med/24018892.
    10.1001/jamaneurol.2013.3185
  42. Lill CM; Schjeide BM; Graetz C; Liu T; Damotte V; Akkad DA; Blaschke P; et al. "Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk.". (2013): http://europepmc.org/abstract/med/23315543.
    10.1136/jmedgenet-2012-101411
  43. Alcina A; Fedetz M; Fernández O; Saiz A; Izquierdo G; Lucas M; Leyva L; et al. "Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.". (2013): http://europepmc.org/abstract/med/23160276.
    10.1136/jmedgenet-2012-101085
  44. Swaminathan B; Cuapio A; Alloza I; Matesanz F; Alcina A; García-Barcina M; Fedetz M; et al. "Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.". (2013): http://europepmc.org/abstract/med/23638056.
    10.1371/journal.pone.0062376
  45. Muñoz-Culla M; Irizar H; Otaegui D. "The genetics of multiple sclerosis: review of current and emerging candidates.". (2013): http://europepmc.org/abstract/med/24019748.
    10.2147/tacg.s29107
  46. Sáenz-Cuesta M; Martínez-Pomar N; de Gracia J; Echaniz P; Villegas E; Prada A; Otaegui D; Matamoros N; Cuadrado E. "TACI mutation in Good's Syndrome: in search of a genetic basis.". (2012): http://europepmc.org/abstract/med/22922270.
    10.1016/j.clim.2012.07.014
  47. Varadé J; Comabella M; Ortiz MA; Arroyo R; Fernández O; Pinto-Medel MJ; Fedetz M; et al. "Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes.". (2012): http://europepmc.org/abstract/med/22194214.
    10.1177/1352458511432741
  48. Cantó E; Reverter F; Morcillo-Suárez C; Matesanz F; Fernández O; Izquierdo G; Vandenbroeck K; et al. "Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.". (2012): http://europepmc.org/abstract/med/22183936.
    10.1177/1352458511433063
  49. Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; et al. "HLA-DRB1*15:01 and multiple sclerosis: a female association?". (2012): http://europepmc.org/abstract/med/22127897.
    10.1177/1352458511426813
  50. Alloza I; Otaegui D; de Lapuente AL; Antigüedad A; Varadé J; Núñez C; Arroyo R; et al. "ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.". (2012): http://europepmc.org/abstract/med/22130326.
    10.1038/gene.2011.81
  51. Cavanillas ML; Fernández O; Comabella M; Alcina A; Fedetz M; Izquierdo G; Lucas M; et al. "Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.". (2011): http://europepmc.org/abstract/med/20944657.
    10.1038/gene.2010.52
  52. Vandenbroeck K; Alloza I; Swaminathan B; Antigüedad A; Otaegui D; Olascoaga J; Barcina MG; et al. "Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.". (2011): http://europepmc.org/abstract/med/20861862.
    10.1038/gene.2010.46
  53. Ruiz-Martínez J; Gorostidi A; Ibañez B; Alzualde A; Otaegui D; Moreno F; López de Munain A; et al. "Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).". (2010): http://europepmc.org/abstract/med/20721916.
    10.1002/mds.23278
  54. Alzualde A; Moreno F; Martínez-Lage P; Ferrer I; Gorostidi A; Otaegui D; Blázquez L; et al. "Somatic mosaicism in a case of apparently sporadic Creutzfeldt-Jakob disease carrying a de novo D178N mutation in the PRNP gene.". (2010): http://europepmc.org/abstract/med/20872767.
    10.1002/ajmg.b.31099
  55. Alcina A; Vandenbroeck K; Otaegui D; Saiz A; Gonzalez JR; Fernandez O; Cavanillas ML; et al. "The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis.". (2010): http://europepmc.org/abstract/med/20508602.
    10.1038/gene.2010.30
  56. Swaminathan B; Matesanz F; Cavanillas ML; Alloza I; Otaegui D; Olascoaga J; Cénit MC; et al. "Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.". (2010): http://europepmc.org/abstract/med/20430450.
    10.1016/j.jneuroim.2010.03.020
  57. Otaegui D; Querejeta R; Arrieta A; Lazkano A; Bidaurrazaga A; Arriandiaga JR; Aldazabal P; Garro MA. "Phospholipase Cbeta4 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes.". (2010): http://europepmc.org/abstract/med/19856080.
    10.1007/s11010-009-0296-x
  58. Sistiaga A; Urreta I; Jodar M; Cobo AM; Emparanza J; Otaegui D; Poza JJ; et al. "Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1.". (2010): http://europepmc.org/abstract/med/19627641.
    10.1017/s0033291709990602
  59. Sistiaga A; Camaño P; Otaegui D; Ibáñez B; Ruiz-Martinez J; Martí-Massó JF; López de Munain A. "Cognitive function in facioscapulohumeral dystrophy correlates with the molecular defect.". (2009): http://europepmc.org/abstract/med/18823405.
    10.1111/j.1601-183x.2008.00442.x
  60. Otaegui D; Zuriarrain O; Castillo-Triviño T; Aransay A; Ruíz-Martinez J; Olaskoaga J; Marti-Masso J; Lopez de Munain A. "Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.". (2009): http://europepmc.org/abstract/med/18755822.
    10.1177/1352458508096682
  61. Otaegui D; Baranzini SE; Armañanzas R; Calvo B; Muñoz-Culla M; Khankhanian P; Inza I; et al. "Differential micro RNA expression in PBMC from multiple sclerosis patients.". (2009): http://europepmc.org/abstract/med/19617918.
    10.1371/journal.pone.0006309
  62. Blázquez L; Azpitarte M; Sáenz A; Goicoechea M; Otaegui D; Ferrer X; Illa I; et al. "Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.". (2008): http://europepmc.org/abstract/med/18563459.
    10.1007/s10048-008-0129-1
  63. López de Munain A; Alzualde A; Gorostidi A; Otaegui D; Ruiz-Martínez J; Indakoetxea B; Ferrer I; et al. "Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.". (2008): http://europepmc.org/abstract/med/17950702.
    10.1016/j.biopsych.2007.08.015
  64. Cárcamo-Orive I; Tejados N; Delgado J; Gaztelumendi A; Otaegui D; Lang V; Trigueros C. "ERK2 protein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential.". (2008): http://europepmc.org/abstract/med/18378228.
    10.1016/j.yexcr.2008.01.020
  65. Quinzii CM; Vu TH; Min KC; Tanji K; Barral S; Grewal RP; Kattah A; et al. "X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1.". (2008): http://europepmc.org/abstract/med/18179901.
    10.1016/j.ajhg.2007.09.013
  66. Goicoechea M; Cía F; San José C; Asensio A; Emparanza JI; Gil AG; López de Cerain A; et al. "Minimizing creatine kinase variability in rats for neuromuscular research purposes.". (2008): http://europepmc.org/abstract/med/18348763.
    10.1258/la.2007.06006e
  67. Otaegui D; Irizar H; Goicoechea M; Pérez-Tur J; Belar M; López de Munain A. "Molecular characterization of putative modulatory factors in two Spanish families with A1555G deafness.". (2008): http://europepmc.org/abstract/med/18391568.
    10.1159/000124280
  68. Blázquez L; De Juan D; Ruiz-Martínez J; Emparanza JI; Sáenz A; Otaegui D; Sistiaga A; et al. "Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population.". (2007): http://europepmc.org/abstract/med/17011669.
    10.1016/j.neurobiolaging.2006.08.009
  69. Otaegui D; Mostafavi S; Bernard CC; Lopez de Munain A; Mousavi P; Oksenberg JR; Baranzini SE. "Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis.". (2007): http://europepmc.org/abstract/med/17785846.
    10.4049/jimmunol.179.6.4074
  70. Otaegui D; Ruíz-Martínez J; Olaskoaga J; Emparanza JI; López de Munain A. "Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis.". (2007): http://europepmc.org/abstract/med/17351762.
    10.1007/s10048-007-0085-1
  71. Otaegui D; Saenz A; Ruiz-Martinez J; Olaskoaga J; López de Munain A. "UCP2 and mitochondrial haplogroups as a multiple sclerosis risk factor.". (2007): http://europepmc.org/abstract/med/17463068.
    10.1177/1352458506070454
  72. Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A. "Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.". (2006): http://europepmc.org/abstract/med/16904828.
    10.1016/j.neulet.2006.07.037
  73. Otaegui D; Sáenz A; Camaño P; Blázquez L; Goicoechea M; Ruíz-Martínez J; Olaskoaga J; Emparanza JA; López de Munain A. "CD24 V/V is an allele associated with the risk of developing multiple sclerosis in the Spanish population.". (2006): http://europepmc.org/abstract/med/16900767.
    10.1191/135248506ms1314sr
  74. Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; et al. "LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.". (2005): http://europepmc.org/abstract/med/15689361.
    10.1093/brain/awh408
  75. Otaegui D; Paisán C; Sáenz A; Martí I; Ribate M; Martí-Massó JF; Pérez-Tur J; López de Munain A. "Mitochondrial polymporphisms in Parkinson's Disease.". (2004): http://europepmc.org/abstract/med/15488317.
    10.1016/j.neulet.2004.08.012
  76. Otaegui D; Sáenz A; Martínez-Zabaleta M; Villoslada P; Fernández-Manchola I; Alvarez de Arcaya A; Emparanza JI; López de Munain A. "Mitochondrial haplogroups in Basque multiple sclerosis patients.". (2004): http://europepmc.org/abstract/med/15471369.
    10.1191/1352458504ms1069oa
  77. Rozen TD; Shanske S; Otaegui D; Lu J; Young WB; Bradley K; DiMauro S; Silberstein SD. "Study of mitochondrial DNA mutations in patients with migraine with prolonged aura.". (2004): http://europepmc.org/abstract/med/15209689.
    10.1111/j.1526-4610.2004.04126.x
  78. Goertsches R; Villoslada P; Comabella M; Montalban X; Navarro A; de la Concha EG; Arroyo R; et al. "A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease.". (2003): http://europepmc.org/abstract/med/14575929.
    10.1016/j.jneuroim.2003.08.026
  79. Mancuso M; Salviati L; Sacconi S; Otaegui D; Camaño P; Marina A; Bacman S; et al. "Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA.". (2002): http://europepmc.org/abstract/med/12391347.
    10.1212/01.wnl.0000028689.93049.9a
  80. Salviati L; Sacconi S; Mancuso M; Otaegui D; Camaño P; Marina A; Rabinowitz S; et al. "Mitochondrial DNA depletion and dGK gene mutations.". (2002): http://europepmc.org/abstract/med/12205643.
    10.1002/ana.10284